Abstract:Objective To investigate the potential protective effect of N-acetylcysteine(NAC)on rotenone-induced apoptosis of PC12 cells and the possible mechanisms.Methods PC12 cells were treated with 1 μmol/L of rotenone for 24 h to establish a cell model of Parkinson's disease(PD).Based on this model,PC12 cells were pretreated with NAC(500 μmol/L)for 30 min before rotenone treatment.Apoptosis rate was analyzed by Annexin Ⅴ-FITC/PI flow cytometry(FCM).Intracellular reactive oxygen species(ROS)was assessed by FCM using the fluorescent dyes,dihydroethidium(DHE)and dihydrorhodamine 123(DHR123).The levels of reduced glutathione(GSH)were determined by using colorimetric method.Caspase-3 activity and mitochondrial membrane potential were also measured.Results After treatment with rotenone for 24 h,apoptosis rate of PC12 cells was reduced to 42.0%.The fluorescence intensity of DHE and DHR123 was increased to 230% and 333% of controls,respectively.GSH levels were reduced to 101 nmol/mg protein after rotenone treatment.Mitochondrial membrane potential was decreased to 46% of controls,and Caspase-3 activity increased to 141% of controls.The differences were all statistically significant as compared with control group.However,after pretreatment with NAC for 30 min,apoptosis rate of PC12 cells was 26.0%,and fluorescence intensity of DHE and DHR123 was 177% and 290% of controls,respectively.GSH levels were 120 nmol/mg protein.Mitochondrial membrane potential was 53% of controls,and Caspase-3 activity was 116% of controls.The differences were all statistically significant as compared with rotenone group.Conclusion These results demonstrated the protective action of NAC on PC12 cells in the rotenone-induced cell model of PD,possibly by alleviating the cell damage from oxidative stress with its antioxidant property.

NAD+ Treatment Can Prevent Rotenone-Induced Increases in DNA Damage, Bax Levels and Nuclear Translocation of Apoptosis-Inducing Factor in Differentiated PC12 Cells

NAD+ Treatment Prevents Rotenone-Induced Apoptosis and Necrosis of Differentiated PC12 Cells

NAD+ Treatment Can Prevent Multiple Rotenone‐induced Apoptotic Changes of PC12 Cells

NAD+ Treatment Can Block Rotenone‐induced Nuclear Apoptotic Changes of PC12 Cells

NAD+ treatment can increase directly the antioxidant capacity of rotenone-treated differentiated PC12 cells

Nicotinamide Mononucleotide Can Decrease Rotenone‐Induced Necrosis and Apoptotic Changes of Neuro2a Cells

Protective Effect of Nicotinamide Adenine Dinucleotide (NAD+) Against Spinal Cord Ischemia-Reperfusion Injury Via Reducing Oxidative Stress-Induced Neuronal Apoptosis.

Nad Plus Treatment Can Attenuate The Oxidative Stress-Induced, Parp-Mediated Atp Depletion In Pc12 Cells

Delayed Treatment of NAD+ Can Restore Intracellular ATP Levels and Prevent PC12 Cell Death Induced by Oxidative Stress

Nicotinamide Mononucleotide Improves Energy Activity and Survival Rate in an in Vitro Model of Parkinson's Disease.

Combined NADPH and the NOX Inhibitor Apocynin Provides Greater Anti-Inflammatory and Neuroprotective Effects in a Mouse Model of Stroke

NAD(+) Administration Decreases Ischemic Brain Damage Partially by Blocking Autophagy in a Mouse Model of Brain Ischemia.

Preventive Effect of N-acetylcysteine against Rotenone-induced Apoptosis in PC12 Cells

NAD+ Induces Autophagy of Neuro2a Cells by Increasing Oxidative Stress

Nicotinamide Adenine Dinucleotide Protects against Spinal Cord Ischemia Reperfusion Injury-Induced Apoptosis by Blocking Autophagy.

Nad(+)/Nadh Metabolism And Nad(+)-Dependent Enzymes In Cell Death And Ischemic Brain Injury: Current Advances And Therapeutic Implications

Reduced Nicotinamide Adenine Dinucleotide Phosphate Inhibits MPTP-Induced Neuroinflammation and Neurotoxicity

Cellular Nad(+) Replenishment Confers Marked Neuroprotection Against Ischemic Cell Death: Role of Enhanced Dna Repair

NAD+ Treatment Decreases Tumor Cell Survival by Inducing Oxidative Stress.

NAD+ Treatment Induces Delayed Autophagy in Neuro2a Cells Partially by Increasing Oxidative Stress

SIRT2, ERK and Nrf2 Mediate NAD+ Treatment-Induced Increase in the Antioxidant Capacity of PC12 Cells under Basal Conditions